Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles

We evaluated adverse events, biodistribution and shedding of oncolytic vaccinia virus encoding CD40 ligand in two Beagles, in preparation for a phase 1 trial in canine cancer patients. Dog 1 received one dose of vaccinia virus and was euthanized 24 hours afterwards, while dog 2 received virus four t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Oncolytics
Main Authors: Autio, Karoliina, Knuuttila, Anna, Kipar, Anja, Pesonen, Sari, Guse, Kilian, Parviainen, Suvi, Rajamäki, Minna, Laitinen-Vapaavuori, Outi, Vähä-Koskela, Markus, Kanerva, Anna, Hemminki, Akseli
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782937/
https://ncbi.nlm.nih.gov/pubmed/27119092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2014.2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares